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Abstract
Random effects models have been widely used to analyze correlated data sets,
and Bayesian techniques have emerged as a powerful tool to fit the models. How-
ever, there has been scarce literature that systematically reviews and summarizes
the recent advances of Bayesian analyses of random effects models. This chapter
reviews the use of the Dirichlet process mixture (DPM) prior to approximate the
distribution of random errors within the general semiparametric random effects
models with parametric random effects for longitudinal data setting and failure
time setting separately. In a survival setting with clusters, we propose a new class of
nonparametric random effects models which is motivated from the accelerated
failure models. We employ a beta process prior to tact clustering and estimation
simultaneously. We analyze a new data set integrated from Alzheimer’s disease
(AD) study to illustrate the presented model and methods.
Keywords: beta process, Dirichlet process mixture, clustered data, longitudinal
data, random effects, survival outcome, nonparametric transformation model
1. Introduction
Random effects models have been widely used as a powerful tool for analyzing
correlated data [1, 2]. The model features a finite number of random terms acting as
latent variables to model unobserved factors; see [3] for a comprehensive review.
Some authors have further proposed semiparametric mixed effect models by
allowing for infinite dimensional random effects [4, 5]. Most of the aforementioned
works draw inferences using frequentist approaches, while Bayesian approaches
have been largely ignored because of the lack of computational feasibility and
expediency. With the advent of the “supercomputer” era, Bayesian analyses have
recently sparked much interest in the setting of random effects models for clustered
data or longitudinal settings. However, there is scarce literature that has systemat-
ically reviewed the Bayesian works in the area.
By extending the traditional random effects models, recent research focus has
shifted to study heterogeneous random effects or nonparametric distributions of
random effects, which arise because of skewness of data, missing covariates, or
unmeasurable subject-specific covariates [6]. The extended random effects models,
termed semiparametric random effects models, improve statistical performance
with added interpretability. Bayesian techniques, which provide a convenient
means to model non-Gaussian distributions, have recently been proposed for
semiparametric random effects model in a variety of settings ([7, 8], among others).
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The discreteness of the Dirichlet process makes it impossible as a prior for estimat-
ing a density. However, as a remedy by convolving with a kernel, Dirichlet process
mixture plays an important role [9].
For censored outcome data, transformation models, which transform the time-
to-event responses using a monotone function and link them to the covariates of
interest, have surged as a strong competitor of the Cox model [10]. Moreover, the
transformation model framework is fairly general. The Cox model and the propor-
tional odd model [11] can be viewed as nonparametric transformation linear models
with some specific error terms; see [12–14]. For correlated data, the transformation
model naturally extends the semiparametric random effects model by directly
incorporating random effects to the transformation functions, treating them as
realizations of an underlying random function. Bayesian analyses have found much
use in this new area. For example, the beta process has been found to be a reason-
able candidate for the prior of the monotone transformation function [15–17].
This chapter focuses on the Bayesian analysis of the transformed linear model
with censored data and in a clustered setting. In many biomedical studies, the
observations are naturally clustered. For example, patients in observational studies
can be grouped in analysis according to a variety of factors, such as age, race,
gender, and hospital, in order to reduce the confounding effects. Following Mallick
and Walker [18], we explore using a mixture of beta distributions and the beta
process as the candidates for the prior distribution of the random transformation
function [17, 19, 20].
The rest of this chapter is structured as follows. Section 2 reviews the use of the
Bayesian approach to infer parametric random effects models. In the setting of
survival analysis, Section 3 proposes a beta process prior to fit random effects model
with nonparametric transformation functions, and Section 4 applies the method to
study the progression of Alzheimer’s disease (AD). Section 5 concludes the chapter
with future research directions.
2. Dirichlet process mixture prior
In parametric random effects models, we considered the situation that the dis-
tribution form of the random error term is unknown. Dirichlet process mixture
(DPM) is used as the prior for the baseline distribution in that error terms used to
be continuous random variables in most situations.
2.1 Linear mixed effects model
With a longitudinal data set Y i, xi, zif g, we posit a mixed effects model with an
AR(1) serial correlation structure:
yi ¼ xiβþ zibi þwi, i ¼ 1, … ,m;
wi ¼ wi1, … ,winið Þ
T;wij ¼ ρwi, j1 þ ϵij, j ¼ 2, … , ni,
(1)
where yi ¼ yi1, … , yini
 T
with yij being the jth response of the ith subject for
i ¼ 1, … ,m, β is a p 1 vector of fixed effect parameters, bi a q 1 Gaussian
random vector representing the subject-specific random effects, xi and zi are ni  p
and ni  q design matrices linking β and bi to yi, respectively, wi ¼ wi1, … ,winið Þ
T
is an ni  1 vector of model errors, ρ is the autoregressive coefficient, and ϵij 0 s are i.i.
d. noises. When ϵij
 
is non-normal, we assume a mixture model:
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fG ϵjσ
2
 
¼
ð
φ ϵju, σ2
 
dG uð Þ, (2)
where φ ju, σ2ð Þ is the probability density function for a normal random variable
with mean u and variance σ2 and G is an unspecified probability distribution of u
satisfying
Ð
udG uð Þ ¼ 0, which ensures that ϵ comes from a mean-zero mixture
distribution.
Replacing the Dirichlet process by an equivalent Pólya urn representation, [8]
employed an empirical likelihood approach with the moment constraints and
developed a posterior adjusted Gibbs sampler for more precise estimation. The
algorithm is computationally feasible.
2.2 Accelerated failure time model
We shift gears to study survival outcomes with a cluster structure. Denote the
data set by Tij,Xij
 
, i ¼ 1,⋯,K, j ¼ 1,⋯, ni, where Tij is the failure time of the jth
subject in the ith cluster and Xij is a vector of associated covariates. To accommo-
date such data, we utilize a general accelerated failure time model:
logTij ¼ X
T
ijβþ εij, i ¼ 1,⋯,K and j ¼ 1,⋯, ni, (3)
where β is a vector of p-dim regression coefficients of interest and εij are inde-
pendent random errors following the distribution with density f i. [7] posed an
exponential tilt on the distributions of error terms to incorporate the cluster het-
erogeneity. That is,
f i tð Þ
f 1 tð Þ
¼ exp θ0i þ θ
T
i q tð Þ
 
, i ¼ 2,⋯,K, (4)
where q tð Þ is a q-dimensional prespecified functions containing potential
covariate information and θi is the corresponding parameter vector with θ0i ¼
log
Ð
exp θTi q tð Þ
 
f 1 tð Þdt
 1h i
: Thus, θi represents the parametric random effects in
the model. Li et al. [7] place the DPM prior on the baseline density f 1 to develop a
set of procedures which improves estimation efficiency through information
pooling.
3. Beta process prior
We now present a nonparametric random effects model for the clustered sur-
vival data with nonparametric monotone link functions. We employ a beta process
as the prior for the baseline function.
Let Tij denote the failure time of the jth subject in the ith cluster, Xij be the
covariate vector for the subject, and Cij be the potential censoring time to the jth
subject in the ith cluster. Assume that Cij is independent of the failure time Tij. Let
Zij ¼ min Tij,Cij
 
and let δij ¼ I Tij <Cij
 
be the censoring indicator. Then the
observed data can be described as
Zij, δij,Xij
 
, i ¼ 1,⋯, n; j ¼ 1,⋯, ni: (5)
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Within each cluster, Tij is linked to Xij via the following transformation model:
lnHi Tij
 
¼ XTijβþ lnεij, i ¼ 1, 2⋯, n, (6)
where εij are i.i.d. variables with a known density function f ε ð Þ and Hi tð Þ are
unknown cluster-specific monotone functions, which are i.i.d. realizations of a
random function and can be viewed as a nonparametric version of random effects
for independent clusters. In a parametric setting, if we set Hi tð Þ ¼ texp bið Þ with bi
being a cluster-specific random effect, Eq. (6) reduces to a classical random effects
model, which has been discussed in Section 2.2. The challenge, however, lies in how
to draw inferences in such a nonparametric setting.
To proceed, let the coefficient vector β be a p-dim unknown vector of interest.
We further assumeHi0s are differentiable with derivative hi tð Þ ¼ H
0
i tð Þ, and then the
likelihood based on the observed data is
L β,H1,⋯,Hnjdatað Þ ¼
Yn
i¼1
Yni
j¼1
p Tij,Xij, δijjHi, β
 
, (7)
where
p t, x, δjH, βð Þ ¼ f ε H tð Þe
xTβ
 
h tð Þex
Tβ
 δ
Sε H tð Þe
xTβ
 1δ
:
Here Sε is the survival function of varepsilon defined by Sε sð Þ ¼ P ε≥ sð Þ.
We develop a Bayesian inference procedure based on model (6). We assume
that the regression coefficient β follows a normal prior:
β  Np 0, σ
2
βIp
 
, (8)
where Ip is the p p dimensional identity matrix. Since Hi is assumed differen-
tiable, we model it with a kernel convolution:
Hi ¼
ð
Φσ   sð ÞdBi sð Þ,
where B is an increasing function and Φσ is the zero-mean normal distribution
with variance σ2. Hence, the derivative of Hi is
hi ¼
ð
ϕσ   sð ÞdBi sð Þ
with ϕσ tð Þ ¼
1
σ
ϕ t
σ
 
: This actually mimics the idea of DPM to smooth beta process
by convolution.
We are in a position to select an appropriate stochastic process used as the prior
of Bi. Beta process, as studied by [16, 17], is an ideal candidate for the prior of a
monotone function. Specifically, beta process BP γ,B0ð Þ with concentration param-
eter γ and a base measure B0 is an increasing Lévy process with independent
increments of the form
dB tð Þ  Beta γdB0 tð Þ, γ 1 dB0 tð Þð Þð Þ:
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Teh et al. [20] showed that a sample from BP γ,B0ð Þ could be represented as
Bi yð Þ ¼
X∞
l¼1
pilI θil ≤ yð Þ, (9)
where pil ¼
Ql
j¼1νil and θil, νilð Þ follows
θil  B0 θð Þ, νil  Beta γ, 1ð Þ l ¼ 1, 2,⋯:
In practice, we need to approximate samples of BP γ,B0ð Þ with a finite dimen-
sional form. Since beta process BP γB0ð Þ can be represented by a stick-breaking
process defined in Eq. (9), a natural approximation is obtained by retaining its first
L components. That is,
B ∗i ¼
XL
l¼1
pilδθil ,
with pil ¼
Ql
j¼1νil, l ¼ 1,⋯,L. Denote ξi ¼ νi1,⋯, νiL, θi1,⋯, θiLð Þ
T and define
H ∗σ z, ξið Þ ¼
XL
l¼1
pilΦσ z θilð Þ, h
∗
σ z, ξið Þ ¼
XL
l¼1
pilϕσ z θilð Þ:
The approximated posterior based on the truncated DP is
π βð Þ
Yn
i¼1
πξ ξið Þ
Yni
j¼1
f Zij,Xij, δijjβ, ξiÞ
 
,
"
(10)
where
f z, x, δjβ, ξð Þ ¼ pε H
∗
σ z, ξð Þexp x
Tβ
  
h ∗σ z, ξð Þexp x
Tβ
  δ
 Pε H
∗
σ z, ξð Þexp x
Tβ
   1δ
:
The samples for β and ξ1, … , ξnð Þ based on the posterior can be obtained with
Markov chain Monte Carlo (MCMC) [21]. In our simulation, we use the R-package
MCMC (https://cran.r-project.org/web/packages/mcmc/index.html) to draw sam-
ples for ξ1, … , ξn and β and use the Metropolis algorithm with a normal working
distribution.
4. An application to Alzheimer’s disease neuroimaging initiative
Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a multisite cooperative
study for the purpose of improving the prevention and treatment of Alzheimer’s
disease. The subjects in the study fall into three groups, cognitively normal (CN)
individuals, mild cognitive impairment (MCI) patients, and early AD patients.
ADNI provides a rich array of patients’ information, including functional magnetic
resonance imaging (fMRI), positron emission tomography (PET), longitudinal
functional cognitive tests scores, blood samples, genetics data, and censored failure
time outcomes. Details of the study can be found at http://adni.loni.usc.edu.
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We focus on the MCI group. MCI is recognized as a transitional stage between
normal cognition and Alzheimer’s disease. The failure time is defined to be the time
that a MCI patient is diagnosed with AD, which will be censored if a MCI patient
remains at the MCI stage at the end of the follow-up time. Wide heterogeneities are
exhibited among the failure times, which may be due to demographics and a variety
of functional clinical biomarkers, such as the brain areas of the hippocampus,
ventricles, and entorhinal cortex. The goal of the analysis is to study the impact of
risk factors on progression to AD.
Using the same data as analyzed by [14], we demonstrate our methodology by
modeling the failure time (the observed time of AD diagnosis from MCI stage in
year) of 281 MCI patients on gender (0 = female, 1 = male), years of education, the
number of apolipoprotein E alleles (0, 1, or 2), and the baseline hippocampal volume.
As age is a strong confounder but the functional form of its impact has not
reached consensus, we elect to model its impact nonparametrically. Specifically, we
use age to form two strata (below and above the median age) and use model (6) to
estimate the stratum-specific transformation functions and the effects of other
covariates. For comparisons, we also fit model (6) with age as a continuous variable
and with a common transformation function. That is, we do not assume the data are
clustered. For both models, the regression errors ε’s are assumed to follow an
exponential distribution with mean 10. In our calculation, we approximate the BPs
by a finite truncation with L ¼ 20. We assume the precision parameter α ¼ 1 and
scale parameter σ2  1=σ2.
Figure 1 illustrates the estimated transformation function H of the failure time
without clustering. The posterior means (PM) and standard errors (SE) of the
regression coefficients in the model are reported in Table 1. We run the MCMC for
Figure 1.
Smoothed transformation function without clustering.
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20,000 iterations with the first 4000 draws discarded as burn-in samples and use
Geweke’s statistic to ensure the convergence of the chains.
Figure 2 illustrates the estimated transformation functions with age-stratified
data, and Table 2 summarizes the posterior means and standard errors of the other
regression coefficients.
The left curve is relatively flat, while the right curve has a sharper slope. This is
consistent with the recognition that AD is an aging disease: elder people above a
certain age threshold tend to progress faster from MCI to AD.
Both Tables 1 and 2 show that none of the biomarkers are significant, whereas
they are statistically significant in the analysis of [14]. One possible conjecture is
that our nonparametric transformation functions may have well captured the
effects of unobserved confounders, which may leave little to be explained by the
observed covariates. More thorough investigation is warranted.
RID AGE PTGENDER PTEDUCAT APOE4 Hipp.
PM 0.9635 0.0069 0.1453 0.0231 0.1817 0.2710
SE 1.3288 0.0841 1.2331 0.1835 0.8616 0.5333
Table 1.
Posterior estimates of regression coefficients with standard errors.
Figure 2.
Smoothed transformation functions with two age-strata: The left curve is the smoothed transformation function
for group aged below the average age; the right curve is the smoothed transformation function for the group aged
over the average age.
RID PTGENDER PTEDUCAT APOE4 Hipp.
PM 0.6399 0.0706 0.0072 0.1349 0.1919
SE 0.9273 0.8491 0.1267 0.6098 0.3716
Table 2.
Posterior estimators of regression coefficients with standard errors.
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5. Future directions
Following [12], we can extend the transformation model (6) by allowing the
error function f ε to be unspecified. In this case, we need to specify the regression
coefficient β to obey some constraints such as β1 ¼ 1 or ∥β∥ ¼ 1 for identifiability.
We will propose to model the error function using a Dirichlet processes mixture
model:
f ε tð Þ ¼
ð
φ tjμ, σ2
 
dG μ, σ2
 
, G  DP α,G0 ¼ N μjμ0, σ
2
0
 
 IG α1, α2ð Þ
 
,
where φ tjμ, σ2ð Þ is a normal kernel with mean μ and variance σ2 and G are
samples from a Dirichlet process DP α1,G0 ¼ N μjμ0, σ
2
0
 
 IG a, bð Þ
 
, where α1 is
the mass parameter and IG ja, bð Þ is the inverse gamma distribution with shape
parameter a and scale parameter b.
In a slightly different context, we may also consider clustering observations by
developing a new nested beta-Dirichlet process prior with companion MCMC algo-
rithms. As there are limited works on functional random effects models that
accommodate clustering structures observed, for example, from neural studies, we
may propose a nested Dirichlet process [19] as the prior of Dirichlet process to
cluster cumulative distribution functions successfully. We envision that such a
nested Bayesian procedure will provide substantial computational expedience for
practitioners and can certainly be applied to studies that cover beyond the neuro-
degenerative and aging diseases.
Acknowledgements
Shen’s research is partially supported by Beijing Natural Science Foundation
1192006 and National Natural Science Foundation of China; Liu’s research is partially
supported by General Research Fund, Research Grants Council, Hong Kong,
15327216, and the Hong Kong Polytechnic University grant YBTR. Data collection and
sharing for this project were funded by the Alzheimer’s Disease Neuroimaging Initia-
tive (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI
(Department of Defense award number W81XWH-12-2-0012). ADNI is funded by
the National Institute on Aging, the National Institute of Biomedical Imaging and
Bioengineering, and through generous contributions from the following: AbbVie,
Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech;
BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate;
Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F.
Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio;
GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research Develop-
ment, LLC.; Johnson & Johnson Pharmaceutical Research Development LLC.;
Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx
Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer
Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition
Therapeutics. The Canadian Institutes of Health Research is providing funds to sup-
port ADNI clinical sites in Canada. Private sector contributions are facilitated by the
Foundation for the National Institutes of Health (www.fnih.org). The grantee orga-
nization is the Northern California Institute for Research and Education, and the
study is coordinated by the Alzheimer’s Therapeutic Research Institute at the Univer-
sity of Southern California. ADNI data are disseminated by the Laboratory for Neuro
Imaging at the University of Southern California.
8
Bayesian Inference on Complicated Data
Data used in preparation of this article were obtained from the Alzheimers
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the
investigators within the ADNI contributed to the design and implementation of
ADNI and/or provided data but did not participate in analysis or writing of this
report. A complete listing of ADNI investigators can be found at: http://adni.loni.
usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
Author details
Junshan Shen1† and Catherine C. Liu2*†
1 Capital University of Economics and Trade, Beijing, China
2 The Hong Kong Polytechnic University, Hong Kong SAR
*Address all correspondence to: macliu@polyu.edu.hk
†These authors contributed equally.
© 2020TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
9
Bayesian Analysis for Random Effects Models
DOI: http://dx.doi.org/10.5772/intechopen.88822
References
[1]Harville DA. Extension of the Gauss–
Markov theorem to include the
estimation of random effect. The Annals
of Statistics. 1976;4:384-395
[2] Laird NM, Ware JH. Random-effects
models for longitudinal data.
Biometrics. 1982;38(2):963-974
[3] Li Y. Random effect models. In:
Pham H, editor. Springer Handbook of
Engineering Statistics. London: Spring-
Verlag; 2006. pp. 687-704
[4] Zeger SL, Diggle PJ. Semiparametric
models for longitudinal data with
application to CD4 cell numbers in HIV
seroconverters. Biometrics. 1994;50(3):
689-699
[5] Li Y, Lin X, Müller P. Bayesian
inference in semiparametric mixed
models for longitudinal data.
Biometrics. 2010;66(1):70-78
[6] Li Y, Mller P, Lin X. Center-adjusted
inference for a nonparametric Bayesian
random effect distribution. Statistica
Sinica. 2011;21:1201-1223
[7] Li Z, Xu X, Shen J. Semiparametric
Bayesian analysis of accelerated failure
time models with cluster structures.
Statistics in Medicine. 2017;36(25):
3976-3989
[8] Shen J, Yu H, Yang J, Liu C.
Semiparametric Bayesian analysis for
longitudinal mixed effects models with
non-normal AR(1) errors. Statistics and
Computing. 2019;29(3):571-583
[9] Ghosal S, van der vaart A.
Fundamentals of Nonparametric
Bayesian Inference. Cambridge:
Cambridge University Press; 2017
[10] Cox DR. Regression models and life
tables (with discussion). Journal of the
Royal Statistical Society: Series B. 1972;
34(2):187-220
[11]Hanson T, Yang M. Bayesian
semiparametric proportional odds
models. Biometrics. 2007;63(1):88
[12]Horowitz JL. Semiparametric
estimation of a regression model with an
unknown transformation of the
dependent variable. Econometrica.
1996;64(1):103-137
[13] Linton O, Sperlich S, Keilegom IV.
Estimation of a semiparametric
transformation model. Annals of
Statistics. 2008;36(2):686-718
[14] Li K, Luo S. Functional joint model
for longitudinal and time-to-event data:
An application to Alzheimer’s disease.
Statistics in Medicine. 2017;36(25):
3560-3572
[15]Müller P, Mitra R. Bayesian
nonparametric inference why and how.
Bayesian Analysis. 2013;8(2):269-302
[16] Kalbfleisch JD. Non-parametric
bayesian analysis of survival time data.
Journal of the Royal Statistical Society.
1978;40(2):214-221
[17]Hjort N. Nonparametric bayes
estimators based on beta processes in
models for life history data. Annals of
Statistics. 1990;18(3):1259-1294
[18]Mallick B, Walker S. A Bayesian
semiparametric transformation model
incorporating frailties. Journal of
Statistical Planning and Inference. 2007;
112(1):159-174
[19] Rodriguez A, Dunson DB,
Gelfand AE. The nested Dirichlet
process. Journal of the American
Statistical Association. 2008;103(483):
1131-1154
[20] Teh YW, Görür D, Ghahramani Z.
Stick-breaking construction for the
Indian buffet process. In: Proceedings of
10
Bayesian Inference on Complicated Data
the Eleventh International Conference
on Artificial Intelligence and Statistics;
Vol. 2; 2007. pp. 556-563
[21]Geyer CJ. Introduction to Markov
chain Monte Carlo. In: Brooks S,
Gelman A, Jones G, Meng X-L, editors.
Handbook of Markov Chain Monte
Carlo. Boca Raton: Chapman and Hall/
CRC; 2011. pp. 3-48
11
Bayesian Analysis for Random Effects Models
DOI: http://dx.doi.org/10.5772/intechopen.88822
